Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by GrahamBon Aug 22, 2023 1:34pm
64 Views
Post# 35600193

RE:RE:RE:RE:Ventripoint sells VMS+ to English children's hospital sells$

RE:RE:RE:RE:Ventripoint sells VMS+ to English children's hospital sells$
ScienceFirst wrote:

GrahamB ... Why bother suddenly, when you mentioned you would not invest in the stock???  Always trying to raise a doubt, in order not to lose face?


@Samburns Asked George and he said they paid for the upgrade
 

@cardinal This is cash in the bank already sale!!!

@cardinal This is cash in the bank already sale!!!



 
I beg to differ.
Just doing due diligence, and I trust in facts, not innuendos or opinions by thiose with a self interest and history of promoting
Why not post the followup posts to those you selected?
3 seperate posters, seem to seee it differently
 
Cherry picking much?
 
SOURCE ceo.ca
@AGS The word "upgrade" was used in the first sentence so that should clear up all confusion lol. This was NOT A SALE. Period. I will use public NR from the company unless they amend it. Not. A. Sale. However this is a very good update and let me just get to huge opportunity staring us in the face - That Hospital is the2nd biggest children's hospital in London and are successfully using VMS and 2. Evelina London children’s heart services (cardiology) cares for around 6,000 patients each year. A very important piece for VPT to have established. Why? Keep reading...14 minutes ago
 
@Investor765 Careful for some missleading information posted here. Today's NR is NOT A SALE, hence not "fully paid for".
 
@Walkoverthestreet  I emailed Jonathan on today's PR and whether this was a sale or a free upgrade.  "This is a free upgrade offer to an important customer. The hospital is an important reference site for other potential buyers." Feel free to email him (address listed on PR). So either GA is wrong or Jonathan 
<< Previous
Bullboard Posts
Next >>